申请人:Abbott Laboratories
公开号:US05506261A1
公开(公告)日:1996-04-09
Compounds of the structure ##STR1## wherein Z is selected from optionally substituted thienyl, thiazolyl, oxazolyl and furyl are potent inhibitors of lipoxygenase enzymes and thus inhibit the biosynthesis of leukotrienes. These compounds are useful in the treatment or amelioration of allergic and inflammatory disease states.
具有结构##STR1##的化合物,其中Z从选择性取代的噻吩基、噻唑基、噁唑基和呋喃基中选择,是脂氧酶酶的有效抑制剂,从而抑制白三烯的生物合成。这些化合物可用于治疗或改善过敏和炎症性疾病状态。